查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829257

2025年全球輔助人工心臟市場報告

Ventricular Assist Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，輔助人工心臟的市場規模迅速擴張，從2024年的21.2億美元成長到2025年的23.7億美元，複合年成長率為11.8%。預測期內的成長主要源自於心臟衰竭盛行率的上升以及器官移植手術需求的不斷增加。

預計未來幾年輔助人工心臟市場將快速成長，到2029年將達到38.7億美元，年複合成長率（CAGR）為13.0%。預測期內的成長可歸因於對目的地治療的需求不斷成長、人口老化、醫療保健支出不斷增加以及人們對心臟衰竭治療認知的提高。預測期內的主要趨勢包括：延長輔助人工心臟的使用壽命、輔助人工心臟的小型化、泵浦技術的進步、對心室輔助裝置安全性和有效性的日益關注、減少輔助人工心臟的副作用以及經皮置入心室輔助人工心臟。

輔助人工心臟(輔助人工心臟) 是一種植入式機械循環裝置，可透過輔助全身血液循環並支持重要器官功能來治療心臟衰竭。美國FDA 已核准多種類型的輔助人工心臟 ，為末期心臟衰竭患者提供長期或永久性支援。

輔助人工心臟的主要類型包括左心室輔助人工心臟(LVAD)、右心室輔助人工心臟(RVAD) 和雙心室輔助人工心臟(BIVAD)。 LVAD 是一種電池供電的機械泵，用於將血液從左心室泵送到重要器官。 LVAD 的設計範圍從經皮到植入式，並採用各種流動機制，包括脈動流和連續流。這些輔助人工心臟用途廣泛，包括移植橋接 (BTT) 治療、最終治療、復健橋接 (BTR) 治療和候選橋接 (BTC) 治療。輔助人工心臟裝置的最終使用者包括醫院、門診手術中心和心臟中心。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司新報告系列的一部分，該系列提供輔助人工心臟輔助人工心臟統計數據，例如全球市場規模、區域佔有率、輔助人工心臟市場佔有率的競爭對手、詳細的心臟輔助設備細分市場、市場趨勢和商業機會，以及在輔助人工心臟輔助人工心臟取得成功所需的數據。這份輔助人工心臟市場研究報告對該行業的當前和未來情況進行了詳細的分析，為您提供所需的一切的完整觀點。

未來五年的預測成長率為13.0%，較我們先前對該市場的預測略有下降0.1%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接影響到美國，導致來自瑞典和英國等主要地區的生物相容性血泵葉輪和經皮傳動系統部件的供應鏈中斷，從而可能導致挽救生命的心臟衰竭支持系統短缺。

心血管疾病發生率的上升推動了輔助人工心臟市場的成長。心血管疾病，包括由高血壓、吸菸、高膽固醇和缺乏運動等因素引起的心臟病，正變得越來越普遍。糖尿病、慢性呼吸系統疾病和高血壓相關心臟病等非傳染性疾病進一步加劇了這些疾病的流行。隨著心血管疾病發生率的上升，對輔助人工心臟是重症心臟病患者的重要支持系統。例如，美國聯邦機構國家醫學圖書館在2022年10月預測，到2035年，45.1%的美國人口將罹患心血管疾病，這些疾病相關的總費用將達到1.1兆美元。因此，預計心血管疾病發生率的上升將在預測期內顯著推動對輔助人工心臟的需求。

提高對心臟衰竭治療的認知是預計推動輔助人工心臟市場成長的關鍵因素。心臟衰竭的特徵是心臟有效泵血能力下降，由冠狀動脈疾病、心臟病發作、高血壓和心肌損傷等疾病引起。提高對心臟衰竭治療的認知預計將推動輔助人工心臟作為治療心臟衰竭的一種手段。值得注意的是，美國心臟協會預測，到 2030 年，心臟衰竭診斷率將增加 46%，受影響人數將超過 800 萬人。隨著心臟衰竭確診人數的持續增加，對可用治療方案的認知不斷提高預計將成為輔助人工心臟市場的主要驅動力。

經皮經皮輔助人工心臟)在市場上越來越受歡迎。 VAD 是一種非搏動性軸流泵，放置在主動脈瓣上，用於從左心室泵血。這些裝置可以減輕左心室的負荷，降低心肌耗氧消費量，增加心摶出量，並降低左心室舒張末期壓力。例如，2022 年 8 月，美國醫療設備美國Abiomed 推出了專為符合條件的經皮患者設計的 Impella 經皮輔助人工心臟提供有效的心臟支持以補償衰竭的左心室，可以作為體外膜氧氣療法(ECMO) 的替代方案或補充其他療法以改善血流動力學。

2022年8月，總部位於愛爾蘭的醫療設備製造商美Medtronic PLC）以9.25億美元收購了Affera公司。此次策略性收購擴大了Medtronic的心導管電氣燒灼術產品組合，並推出了其首個心臟定位和導航平台，該平台包括射頻消融、局部脈衝磁場治療和整合診斷解決方案。 Affera公司是一家總部位於美國的醫療科技公司，專注於心臟定位和導航系統以及基於導管的心導管電氣燒灼術技術。

參與輔助人工心臟市場的主要企業包括 Abiomed、雅培實驗室、美敦力、LivaNova PLC、Terumo Corporation、Berlin Heart GmbH、Cirtec、Jarvik Heart、SynCardia Systems LLC、Calon Cardio-Technology Ltd、美國醫學有限公司、 Inc.、BiVACOR Inc.、ReliantHeart Inc.、Cardiac Assist Inc.、Heart Ware International 和 Braille Biomedica Ltd.。

2024年，北美是輔助人工心臟市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。輔助人工心臟市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

輔助人工心臟市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、美國、義大利、西班牙和加拿大。

輔助人工心臟市場包括搏動式和非搏動式左心室輔助裝置 (LVAD) 的銷售。該市場的價值為“出廠價”，即商品製造商或生產商銷售的商品價值，無論是銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）還是直接銷售給最終客戶。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球輔助人工心臟：PESTEL 分析（政治、社會、技術、環境、法律、促進因素和限制因素）
  • 最終用途產業分析
  • 全球輔助人工心臟市場：成長率分析
  • 全球輔助人工心臟市場表現：規模與成長，2019-2024
  • 全球輔助人工心臟市場預測：規模與成長，2024-2029年，2034年
  • 全球輔助人工心臟：總潛在市場（TAM）

第6章 市場細分

  • 全球輔助人工心臟市場：依產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 左心室輔助裝置（LVAD）
  • 右心室輔助裝置（RVAD）
  • 雙心室輔助裝置（BIVAD）
  • 全球輔助人工心臟市場類型、表現及預測（2019-2024 年、2024-2029 年、2034 年）
  • 脈動流
  • 連續流
  • 全球輔助人工心臟市場：設計、性能及預測（2019-2024、2024-2029、2034）
  • 經皮心室輔助裝置
  • 植入式輔助人工心臟
  • 全球輔助人工心臟市場：應用、效能及預測，2019-2024年、2024-2029年、2034年
  • 移植前橋接（BTT）治療
  • 目的地療法
  • 復健橋樑療法（BTR）
  • 候選人資格橋樑（BTC）治療
  • 全球輔助人工心臟市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 心臟病中心
  • 全球左心室輔助人工心臟市場：左心室輔助人工心臟（LVAD）細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式左心室輔助裝置
  • 暫時 LVAD
  • 全球右心室輔助人工心臟裝置（RVAD）市場：細分、類型、績效及預測，2019-2024年、2024-2029年、2034年
  • 植入式右心室輔助裝置
  • 臨時 RVAD
  • 全球雙心室輔助人工心臟裝置 (BIVAD) 市場：細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 全力支持BIVAD
  • 混合型雙側輸尿管假體

第7章 區域和國家分析

  • 全球輔助人工心臟市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球輔助人工心臟市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 輔助人工心臟市場：競爭格局
  • 輔助人工心臟市場：公司簡介
    • Abiomed
    • Abbott Laboratories
    • Medtronic
    • LivaNova PLC
    • Terumo Corporation

第31章：其他領先和創新企業

  • Berlin Heart GmbH
  • Cirtec
  • Jarvik Heart Inc.
  • SynCardia Systems LLC.
  • Calon Cardio-Technology Ltd
  • Huadong Medicine Co. Ltd
  • Shenzhen Hexin Zondan Medical Equipment Co. Ltd
  • Sun Medical Technology Research Corp.
  • Boston Scientific Corporation
  • CorWave SA
  • CH生物醫學（美國）公司
  • Evaheart Inc
  • BiVACOR Inc
  • ReliantHeart Inc
  • Cardiac Assist Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年輔助人工心臟市場：提供新機會的國家
  • 2029年輔助人工心臟市場：細分市場帶來新機會
  • 輔助人工心臟市場 2029 年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r26022u

A ventricular assist device (VAD) is an implantable mechanical circulatory device used to treat heart failure by aiding blood circulation throughout the body, supporting vital organ function. The US FDA has approved a diverse range of VADs, offering long-term or permanent assistance for patients with end-stage heart failure.

The primary types of VADs include left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). LVADs, battery-operated mechanical pumps, help propel blood from the left ventricle to vital organs. They vary in design as transcutaneous or implantable devices and operate with different flow mechanisms such as pulsatile flow and continuous flow. These devices are used for various purposes including bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. End-users of VADs include hospitals, ambulatory surgical centers, and cardiology centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The ventricular assist device market research report is one of a series of new reports from The Business Research Company that provides ventricular assist device market statistics, including ventricular assist device industry global market size, regional shares, competitors with a ventricular assist device market share, detailed ventricular assist device market segments, market trends and opportunities, and any further data you may need to thrive in the ventricular assist device industry. This ventricular assist device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ventricular assist device market size has grown rapidly in recent years. It will grow from $2.12 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to an increase in the prevalence of heart failure and a rise in demand for organ transplantation procedures.

The ventricular assist device market size is expected to see rapid growth in the next few years. It will grow to $3.87 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to the increasing need for destination therapy, aging population, increasing healthcare expenditure and a rise in awareness regarding heart failure treatment. Major trends in the forecast period include focus on lengthening effective life of VADs, miniaturization of VADs, advanced pump technologies, increased focus on VAd safety and effectiveness, focus on reduction in side effects of VADs and percutaneously inserted ventricular assist devices.

The forecast of 13.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for biocompatible blood pump impellers and percutaneous drive line components, sourced from key regions such as Sweden and the United Kingdom, could lead to shortages in life-saving heart failure support systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cardiovascular disorders is driving growth in the ventricular assist device market. Cardiovascular disorders, which include heart diseases caused by factors such as high blood pressure, smoking, high cholesterol, and inactivity, are increasingly common. The prevalence of these conditions is further exacerbated by non-communicable diseases like diabetes, chronic respiratory illnesses, and heart attacks linked to hypertension. As the incidence of cardiovascular disorders rises, so does the demand for ventricular assist devices, which serve as crucial support systems for severely ill cardiac patients. For instance, in October 2022, the National Library of Medicine, a US-based federal agency, projected that by 2035, 45.1% of the US population will have cardiovascular disease, with total costs associated with these diseases expected to reach $1.1 trillion. Consequently, the increasing prevalence of cardiovascular disorders is anticipated to significantly boost demand for ventricular assist devices during the forecast period.

The increased awareness surrounding heart failure treatment is a pivotal factor expected to fuel the growth of the ventricular assist device market. Heart failure, characterized by the heart's diminished ability to effectively pump blood, can result from conditions such as coronary artery disease, heart attacks, high blood pressure, and heart muscle damage. The escalating awareness about heart failure treatments is anticipated to drive the adoption of ventricular assist devices as a means to address heart failure. Notably, the American Heart Association projects a 46% increase in heart failure diagnoses by 2030, surpassing 8 million individuals affected. As the number of people diagnosed with heart failure continues to rise, the heightened awareness of available treatment options is poised to be a key driver for the ventricular assist device market.

The adoption of percutaneously inserted ventricular assist devices is gaining prominence in the market. Percutaneously inserted ventricular assist devices are non-pulsatile axial flow pumps positioned across the aortic valve, pumping blood from the left ventricle. These devices alleviate the load on the left ventricle, decrease myocardial oxygen consumption, enhance cardiac output, and reduce left ventricular end-diastolic pressure. As an example, in August 2022, Abiomed Inc., a US-based medical device company, introduced the Impella, a percutaneous VAD designed for eligible pediatric patients in the USA. The Impella device provides effective cardiac support to compensate for a failing left ventricle and can serve as an alternative to extracorporeal membrane oxygenation (ECMO) or complement other therapies to enhance hemodynamics.

In August 2022, Medtronic PLC, an Ireland-based medical device company, acquired Affera, Inc. for $925 million. This strategic acquisition broadens Medtronic's portfolio of cardiac ablation products, introducing their initial cardiac mapping and navigation platform. The platform includes radiofrequency ablation, focal pulsed field, and an integrated diagnostic solution. Affera Inc., a US-based medical technology company, specializes in cardiac mapping and navigation systems, along with catheter-based cardiac ablation technologies.

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ventricular assist device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The ventricular assist device market consists of sales of pulsatile and nonpulsatile LVADs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ventricular Assist Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ventricular assist device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ventricular assist device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ventricular assist device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).
  • 2) By Type: Pulsatile Flow, Continuous Flow
  • 3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
  • 4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
  • 5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres
  • Subsegments:
  • 1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs; Temporary LVADs
  • 2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs; Temporary RVADs
  • 3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs; Hybrid BIVADs
  • Companies Mentioned: Abiomed; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation; Berlin Heart GmbH; Cirtec; Jarvik Heart Inc.; SynCardia Systems LLC.; Calon Cardio-Technology Ltd; Huadong Medicine Co. Ltd; Shenzhen Hexin Zondan Medical Equipment Co. Ltd; Sun Medical Technology Research Corp.; Boston Scientific Corporation; CorWave SA; CH Biomedical (USA) Inc; Evaheart Inc; BiVACOR Inc; ReliantHeart Inc; Cardiac Assist Inc; Heart Ware International; Braile Biomedica Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ventricular Assist Device Market Characteristics

3. Ventricular Assist Device Market Trends And Strategies

4. Ventricular Assist Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ventricular Assist Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ventricular Assist Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ventricular Assist Device Market Growth Rate Analysis
  • 5.4. Global Ventricular Assist Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ventricular Assist Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ventricular Assist Device Total Addressable Market (TAM)

6. Ventricular Assist Device Market Segmentation

  • 6.1. Global Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)
  • 6.2. Global Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pulsatile Flow
  • Continuous Flow
  • 6.3. Global Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices
  • 6.4. Global Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bridge-to-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge-to-Recovery (BTR) Therapy
  • Bridge-to-Candidacy (BTC) Therapy
  • 6.5. Global Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiology Centers
  • 6.6. Global Ventricular Assist Device Market, Sub-Segmentation Of Left Ventricular Assist Devices (LVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable LVADs
  • Temporary LVADs
  • 6.7. Global Ventricular Assist Device Market, Sub-Segmentation Of Right Ventricular Assist Devices (RVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable RVADs
  • Temporary RVADs
  • 6.8. Global Ventricular Assist Device Market, Sub-Segmentation Of Biventricular Assist Devices (BIVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Full Support BIVADs
  • Hybrid BIVADs

7. Ventricular Assist Device Market Regional And Country Analysis

  • 7.1. Global Ventricular Assist Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ventricular Assist Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ventricular Assist Device Market

  • 8.1. Asia-Pacific Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ventricular Assist Device Market

  • 9.1. China Ventricular Assist Device Market Overview
  • 9.2. China Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ventricular Assist Device Market

  • 10.1. India Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ventricular Assist Device Market

  • 11.1. Japan Ventricular Assist Device Market Overview
  • 11.2. Japan Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ventricular Assist Device Market

  • 12.1. Australia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ventricular Assist Device Market

  • 13.1. Indonesia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ventricular Assist Device Market

  • 14.1. South Korea Ventricular Assist Device Market Overview
  • 14.2. South Korea Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ventricular Assist Device Market

  • 15.1. Western Europe Ventricular Assist Device Market Overview
  • 15.2. Western Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ventricular Assist Device Market

  • 16.1. UK Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ventricular Assist Device Market

  • 17.1. Germany Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ventricular Assist Device Market

  • 18.1. France Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ventricular Assist Device Market

  • 19.1. Italy Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ventricular Assist Device Market

  • 20.1. Spain Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ventricular Assist Device Market

  • 21.1. Eastern Europe Ventricular Assist Device Market Overview
  • 21.2. Eastern Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ventricular Assist Device Market

  • 22.1. Russia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ventricular Assist Device Market

  • 23.1. North America Ventricular Assist Device Market Overview
  • 23.2. North America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ventricular Assist Device Market

  • 24.1. USA Ventricular Assist Device Market Overview
  • 24.2. USA Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ventricular Assist Device Market

  • 25.1. Canada Ventricular Assist Device Market Overview
  • 25.2. Canada Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ventricular Assist Device Market

  • 26.1. South America Ventricular Assist Device Market Overview
  • 26.2. South America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ventricular Assist Device Market

  • 27.1. Brazil Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ventricular Assist Device Market

  • 28.1. Middle East Ventricular Assist Device Market Overview
  • 28.2. Middle East Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ventricular Assist Device Market

  • 29.1. Africa Ventricular Assist Device Market Overview
  • 29.2. Africa Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ventricular Assist Device Market Competitive Landscape And Company Profiles

  • 30.1. Ventricular Assist Device Market Competitive Landscape
  • 30.2. Ventricular Assist Device Market Company Profiles
    • 30.2.1. Abiomed Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Ventricular Assist Device Market Other Major And Innovative Companies

  • 31.1. Berlin Heart GmbH
  • 31.2. Cirtec
  • 31.3. Jarvik Heart Inc.
  • 31.4. SynCardia Systems LLC.
  • 31.5. Calon Cardio-Technology Ltd
  • 31.6. Huadong Medicine Co. Ltd
  • 31.7. Shenzhen Hexin Zondan Medical Equipment Co. Ltd
  • 31.8. Sun Medical Technology Research Corp.
  • 31.9. Boston Scientific Corporation
  • 31.10. CorWave SA
  • 31.11. CH Biomedical (USA) Inc
  • 31.12. Evaheart Inc
  • 31.13. BiVACOR Inc
  • 31.14. ReliantHeart Inc
  • 31.15. Cardiac Assist Inc

32. Global Ventricular Assist Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ventricular Assist Device Market

34. Recent Developments In The Ventricular Assist Device Market

35. Ventricular Assist Device Market High Potential Countries, Segments and Strategies

  • 35.1 Ventricular Assist Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ventricular Assist Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ventricular Assist Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer